These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 2581141)
1. Dihydropyridine receptors in muscle are voltage-dependent but most are not functional calcium channels. Schwartz LM; McCleskey EW; Almers W Nature; 1985 Apr 25-May 1; 314(6013):747-51. PubMed ID: 2581141 [TBL] [Abstract][Full Text] [Related]
2. Are dihydropyridine binding sites voltage sensitive calcium channels? Miller RJ; Freedman SB Life Sci; 1984 Mar; 34(13):1205-21. PubMed ID: 6323901 [No Abstract] [Full Text] [Related]
3. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes. Williams LT; Tremble P J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938 [TBL] [Abstract][Full Text] [Related]
4. Diphenylhydantoin blocks cardiac calcium channels and binds to the dihydropyridine receptor. Yatani A; Hamilton SL; Brown AM Circ Res; 1986 Sep; 59(3):356-61. PubMed ID: 2429782 [TBL] [Abstract][Full Text] [Related]
5. High-affinity antibodies to the 1,4-dihydropyridine Ca2+-channel blockers. Campbell KP; Sharp A; Strom M; Kahl SD Proc Natl Acad Sci U S A; 1986 May; 83(9):2792-6. PubMed ID: 3010317 [TBL] [Abstract][Full Text] [Related]
6. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110. Ferry DR; Goll A; Glossmann H Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337 [TBL] [Abstract][Full Text] [Related]
7. A calcium antagonist drug binding site in skeletal muscle sarcoplasmic reticulum: evidence for a calcium channel. Fairhurst AS; Thayer SA; Colker JE; Beatty DA Life Sci; 1983 Mar; 32(12):1331-9. PubMed ID: 6300579 [TBL] [Abstract][Full Text] [Related]
8. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes. Maan AC; Ptasienski J; Hosey MM J Pharmacol Exp Ther; 1986 Dec; 239(3):768-74. PubMed ID: 2432217 [TBL] [Abstract][Full Text] [Related]
9. The 1,4-dihydropyridine receptor: a regulatory component of the Ca2+ channel. Triggle DJ; Janis RA J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S949-55. PubMed ID: 6085383 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive mechanism of action and binding sites of nitrendipine. Triggle DJ Am J Cardiol; 1986 Sep; 58(8):35D-38D. PubMed ID: 2429539 [TBL] [Abstract][Full Text] [Related]
11. Reversible dihydropyridine isothiocyanate binding to brain calcium channels. Greenberg DA; Cooper EC; Carpenter CL J Neurochem; 1985 Jan; 44(1):319-21. PubMed ID: 2578060 [TBL] [Abstract][Full Text] [Related]
12. [3H]nitrendipine labelling of the Ca2+ channel in skeletal muscle. Fosset M; Jaimovich E; Delpont E; Lazdunski M Eur J Pharmacol; 1982 Dec; 86(1):141-2. PubMed ID: 6297924 [No Abstract] [Full Text] [Related]
13. Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins. Dunn SM; Bladen C Biochemistry; 1991 Jun; 30(23):5716-21. PubMed ID: 1645998 [TBL] [Abstract][Full Text] [Related]
14. A functional correlate for the dihydropyridine binding site in rat brain. Middlemiss DN; Spedding M Nature; 1985 Mar 7-13; 314(6006):94-6. PubMed ID: 2579341 [TBL] [Abstract][Full Text] [Related]
15. Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists. Sanguinetti MC; Kass RS Circ Res; 1984 Sep; 55(3):336-48. PubMed ID: 6088117 [TBL] [Abstract][Full Text] [Related]
16. Molecular properties of the slow inward calcium channel. Molecular weight determinations by radiation inactivation and covalent affinity labeling. Venter JC; Fraser CM; Schaber JS; Jung CY; Bolger G; Triggle DJ J Biol Chem; 1983 Aug; 258(15):9344-8. PubMed ID: 6308002 [TBL] [Abstract][Full Text] [Related]
17. Calcium channel activity in a purified dihydropyridine-receptor preparation of skeletal muscle. Smith JS; McKenna EJ; Ma JJ; Vilven J; Vaghy PL; Schwartz A; Coronado R Biochemistry; 1987 Nov; 26(22):7182-8. PubMed ID: 2447943 [TBL] [Abstract][Full Text] [Related]
18. Solubilization and affinity labeling of a dihydropyridine binding site from skeletal muscle: effects of temperature and diltiazem on [3H]dihydropyridine binding to transverse tubules. Kirley TL; Schwartz A Biochem Biophys Res Commun; 1984 Aug; 123(1):41-9. PubMed ID: 6089800 [TBL] [Abstract][Full Text] [Related]
19. [3H]nitrendipine receptors as markers of a class of putative voltage-sensitive Ca2+ channels in normal human skeletal muscle and in muscle from Duchenne muscular dystrophy patients. Desnuelle C; Renaud JF; Delpont E; Serratrice G; Lazdunski M Muscle Nerve; 1986 Feb; 9(2):148-51. PubMed ID: 2419753 [TBL] [Abstract][Full Text] [Related]
20. Binding of the calcium channel blocker nitrendipine to its receptor in purified sarcolemma from canine cardiac ventricle. Sarmiento JG; Janis RA; Colvin RA; Triggle DJ; Katz AM J Mol Cell Cardiol; 1983 Feb; 15(2):135-7. PubMed ID: 6304327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]